TY  - JOUR 
AU  - Calamia, Valentina
AU  - Lourido Salas, Lucía
AU  - Fernández Puente, Patricia
AU  - Mateos Martín, Jesús
AU  - Rocha Loureda, Beatriz
AU  - Montell, Eulalia
AU  - Ruiz Romero, Cristina
AU  - BLANCO GARCIA, FRANCISCO JAVIER
PY  - 2012
SN  - 1478-6354
UR  - http://hdl.handle.net/20.500.11940/7468
AB  - Introduction: Chondroitin sulfate (CS) is a symptomatic slow-acting drug for osteoarthritis (OA) widely used in the clinic. The aim of this work is to find proteins whose secretion from cartilage cells under proinflammatory stimuli (IL-1β) is...
LA  - eng
KW  - Chondrocytes
KW  - Complemento C1r
KW  - Complemento C1s
KW  - Anti-Inflammatory Agents
KW  - Cell Adhesion Molecules
KW  - Matrix Metalloproteinase 1
KW  - Anabolic Agents
TI  - Secretome analysis of chondroitin sulfate-treated chondrocytes reveals anti-angiogenic, anti-inflammatory and anti-catabolic properties
DO  - 10.1186/ar4040
T2  - ARTHRITIS RESEARCH & THERAPY
VL  - 14
ER  -